NEWS

★IR：カテゴリメニュー

タブV2

All
IR Library
Topics

2024/09/05

IR Library

1Q FY2024 update from OMEGA Investment [PDF：892KB]
2024/08/14

IR Library

[Presentation] Financial Results for 1Q FY 2024 [PDF：1388KB]
2024/08/14

IR Library

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025 [PDF：222KB]
2024/06/18

IR Library

Business alliance agreement for co-development of biosimilars [PDF：104KB]
2024/06/11

IR Library

Announcement of the Conclusion of an Outsourcing Agreement to Strengthen Collaboration with Biotech Ventures [PDF：131KB]
2024/05/30

IR Library

4Q FY2023 update from OMEGA Investment [PDF：818KB]
2024/05/14

IR Library

[Presentation] Financial Results for the FY 2023 [PDF：1786KB]
2024/05/14

IR Library

Summary of Financial Results for the Fiscal Year Ended March 31, 2024 (Non-consolidated) [PDF：212KB]
2024/03/25

IR Library

Announcement of revisions to FY2023 financial guidance [PDF：78KB]
2024/03/18

IR Library

Announcement of the loan arrangement from Japan Finance Corporation [PDF：74KB]
2024/03/11

IR Library

Announcement of manufacturing of SHED Master Cell Bank in compliance with US FDA Standards [PDF：98KB]
2024/03/08

IR Library

Notice of the Nomination of Candidates for Board Directors and Corporate Auditors [PDF：105KB]
2024/02/27

お知らせIR Library

3Q FY2023 update from OMEGA Investment [PDF：695KB]
2024/02/07

IR Library

[Presentation] Financial Results for 3Q FY 2023 [PDF：922KB]
2024/02/07

IR Library

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024
[PDF：363KB]
2024/01/12

IR Library

Announcement of establishment of a subsidiary in the cell therapy business (regenerative medicine) through a company split (simplified incorporation-type company split) [PDF：230KB]
2023/12/21

IR Library

Announcement of the bank loan arrangement from Mizuho Bank, Ltd. for increased orders of GBS-007 [PDF：147KB]
2023/11/21

IR Library

Announcement of the launch of Pegfilgrastim biosimilar [PDF：149KB]
2023/11/14

IR Library

2Q FY2023 update from OMEGA Investment [PDF：759KB]
2023/11/13

IR Library

Announcement of research results at the 43^rd Annual Scientific Meeting of the Japanese Society of Ocular Pharmacology -Optic neuroprotective effect with SHED- [PDF：126KB]
2023/11/08

IR Library

Summary of Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2024 [PDF：255KB]
2023/11/08

IR Library

[Presentation] Financial Results for 2Q FY 2023 [PDF：1089KB]
2023/10/16

IR Library

Announcement of enrollment of the first case of clinical research plan for children with cerebral palsy under the initiative of Nagoya University [PDF：142KB]
2023/09/27

IR Library

Announcement of approval of additional indication of Ranibizumab BS [PDF：141KB]
2023/09/25

IR Library

Announcement of Receiving Manufacturing and Sales Approval for biosimilar in the Oncology in Japan [PDF：204KB]
2023/08/15

IR Library

1Q FY2023 update from OMEGA Investment[PDF：982KB]
2023/08/07

IR Library

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024[PDF：339KB]
2023/08/07

IR Library

[Presentation] Financial Results for 1Q FY 2023[PDF：1360KB]
2023/07/14

IR Library

Correction of the press release on July 10, 2023 [PDF：187KB]
2023/07/10

IR Library

Working Capital Financing for stable supply for GBS-007 (18th series of stock acquisition rights with exercise price adjustment clause) [PDF：206KB]
2023/07/10

IR Library

[Presentation] Working Capital Financing for Stable Supply of GBS-007 [PDF：686KB]
2023/06/29

IR Library

Appointment of new CEO [PDF：156KB]
2023/06/06

IR Library

Announcement of organizational and personnel changes [PDF：196KB]
2023/06/06

IR Library

Announcement of partial changes in the Articles of Incorporation [PDF：143KB]
2023/06/06

IR Library

Announcement of appointment of New CEO and Board Directors [PDF：249KB]
2023/05/22

IR Library

Establishment of stable storage and transportation system of SHED [PDF：192KB]
2023/05/19

IR Library

Company note 4QFY2022 update from OMEGA Investment [PDF：1155KB]
2023/05/12

IR Library

[Presentation] Financial Results for the FY 2022 [PDF：1817KB]
2023/05/12

IR Library

Summary of Financial Results for the Fiscal Year Ended March 31, 2023 (Non-consolidated) [PDF：374KB]
2023/05/08

IR Library

Announcement of presentation on basic research results of SHED at American Society of Gene & Cell Therapy (ASGCT)[PDF：143KB]
2023/02/20

IR Library

The Company’s opinion on Glass Lewis’ voting recommendation on the agenda item to be proposed at the extraordinary general meeting of shareholders [PDF：152KB]
2023/02/20

IR Library

Update of clinical research plan of Nagoya University [PDF：144KB]
2023/02/13

IR Library

Company note 3Q FY2023/3 update from OMEGA Investment [PDF：800KB]
2023/02/10

IR Library

Update from Heartseed Inc.: Successful transplantation of the first case in the Phase I/II LAPiS study of HS-001, a myocardial regenerative therapy utilizing iPS cells [PDF：117KB]
2023/02/07

IR Library

[Presentation] Financial Results for the Third Quarter of FY2022 [PDF：1790KB]
2023/02/07

IR Library

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
(Excerpt from Japanese version) [PDF：465KB]
2023/01/30

IR Library

Update of clinical research plan of Nagoya University [PDF：144KB]
2023/01/26

IR Library

ANALYST NET Company Report was released by Fair Research Inc. [PDF：1372KB]
2023/01/13

IR Library

The Company’s opinion on shareholders’ proposal (Excerpt from Japanese version)
[PDF：191KB]
2023/01/13

IR Library

Announcement of approval of additional indication of Ranibizumab BS (Excerpt from Japanese version) [PDF：206KB]

2024/09/05

IR Library

1Q FY2024 update from OMEGA Investment [PDF：892KB]
2024/08/14

IR Library

[Presentation] Financial Results for 1Q FY 2024 [PDF：1388KB]
2024/08/14

IR Library

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025 [PDF：222KB]
2024/06/18

IR Library

Business alliance agreement for co-development of biosimilars [PDF：104KB]
2024/06/11

IR Library

Announcement of the Conclusion of an Outsourcing Agreement to Strengthen Collaboration with Biotech Ventures [PDF：131KB]
2024/05/30

IR Library

4Q FY2023 update from OMEGA Investment [PDF：818KB]
2024/05/14

IR Library

[Presentation] Financial Results for the FY 2023 [PDF：1786KB]
2024/05/14

IR Library

Summary of Financial Results for the Fiscal Year Ended March 31, 2024 (Non-consolidated) [PDF：212KB]
2024/03/25

IR Library

Announcement of revisions to FY2023 financial guidance [PDF：78KB]
2024/03/18

IR Library

Announcement of the loan arrangement from Japan Finance Corporation [PDF：74KB]

2019/11/22

Announcement on Series B Funding by Heartseed Inc.

We are pleased to announce that Heartseed Inc., our investee company, has raised Series B funding.
For the details, please refer to the link below.

Heartseed Inc.
Heartseed raises $26 Million in Series B Funding
http://www.heartseed.jp/pdf/191122_PR_E.pdf

News List

Our Goal

Business

Features / Strength

Pipeline

Company Profile

IR Information

NEWS

Announcement on Series B Funding by Heartseed Inc.